logo
logo

Gene Centric Therapeutics, Inc. announced it raised $1.2 Million in an initial filing from an offering of $1.2 Million

Jan 13, 2021over 4 years ago

Amount Raised

$1.2 Million

DurhamBiotechnology

Company Information

Company

GeneCentric Therapeutics

Location

100 CAPITOLA DRIVE

Durham, North Carolina, United States

About

GeneCentric is a precision oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression. With a foundation built on over a decade of research into gene expression, including the PurIST® test (commercially available through Tempus), GeneCentric has pioneered ExpressCT™, a proprietary technology that enables gene expression inference directly from circulating tumor DNA (ctDNA). This innovation is embodied in the GenomicsNext™ platform, a multimodal liquid biopsy solution that simultaneously detects DNA alterations and inferred gene expression from a single blood sample.

Related People